Hengrui Pharma

Forecast & Rating20 analysts currently cover Hengrui Pharma, with about 95.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥80.33, about 49.1% upside from the current price of ¥53.89. Price targets range from ¥65.00 to ¥123.00 — a wide spread, showing clear disagreement over just how much Hengrui Pharma can rise. Historically, about 46.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Hengrui Pharma closely still see room for the stock to rise. Data as of Jul 25, 2026; for reference only and not investment advice.